Analysis Amicus Therapeutics Inc (FOLD)
6/5/2024
Analysis of Amicus Therapeutics Inc (FOLD)
Amicus Therapeutics Inc (symbol: FOLD) has shown some volatility in its stock price recently. The Relative Strength Index (RSI) values have been fluctuating around the mid-range, indicating a balanced market sentiment. The Moving Average Convergence Divergence (MACD) indicator has been hovering around the zero line, suggesting a lack of strong trend direction.The stock price has been moving within a range, with the Simple Moving Average (SMA) and Exponential Moving Average (EMA) values reflecting this sideways movement. The Weighted Moving Average (WMA) has also been relatively stable.
Overall, based on the recent data, it seems that FOLD is currently in a consolidation phase with no clear trend direction. Traders and investors may need to wait for a breakout or further confirmation signals before making trading decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has a strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has a beta above 1, indicating higher volatility compared to the market. The company's stock has seen fluctuations between its fifty-two-week low and high prices.
Valuation metrics show a relatively high PEG ratio and forward PE ratio. The company's market capitalization and enterprise value are substantial, with a high price-to-book ratio and price-to-sales ratio. The enterprise value to EBITDA and enterprise value to revenue ratios are also notable.
The stock price summary includes moving averages, fifty-two-week low and high prices, and the percentage change over the past year.
Lastly, dividends and splits information shows the company's dividend dates, split history, and dividend yield metrics. The company has a consistent dividend payout and yield.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, suggesting efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
7. The company has been able to maintain a healthy EBITDA margin, indicating strong operational performance.
8. Overall, the financial performance of the company seems to be improving, with a focus on revenue growth and cost management.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been managing its short-term and long-term debts effectively.
7. Accumulated depreciation has been significant, affecting the value of non-current assets.
8. Provision for risks and charges has been relatively stable over the years.
9. The company has been investing in leases, land, and improvements consistently.
10. Overall, the financial health of the company seems stable and improving over the years.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows growth compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth compared to the EPS of $1.35 from the same quarter a year ago.
3. For the current year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects an increase from the EPS of $5.67 from the previous year.
4. Looking ahead to the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests growth compared to the EPS of $6.10 from the current year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, representing a 2% increase from the same period last year. The number of analysts providing estimates is 25.
Looking ahead to the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a projected growth rate of 3% compared to the previous year. The number of analysts remains at 25.
For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, showing a 1% growth from the previous year. The number of analysts providing estimates has increased to 38.
In the following fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a more significant growth rate of 6% compared to the current fiscal year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in the upcoming quarters and years, with a slightly more optimistic outlook for the next fiscal year.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is slightly higher at 5.2%.
3. Current Year: The growth rate for the current year is estimated to be 7.6%.
4. Next Year: The growth rate is expected to increase to 9.7% for the next year.
5. Past 5 Years: The company has shown a strong growth rate of 20.1% per annum over the past 5 years.
6. Next 5 Years: The estimated growth rate for the next 5 years on a per annum basis is 9.7%.
Overall, the company is expected to maintain a steady growth rate in the upcoming periods, with a significant increase projected for the next year compared to the current year. The past performance also indicates a strong growth trajectory over the last 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are predicting a potential increase in the price of the security, with a median estimate of $201.43. However, it's worth noting that there is a wide range of predictions, from a low of $164 to a high of $275. The current price of the security is $192.25.
MACD of FOLD
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
